Putnam Investments LLC Merck & Co., Inc. Transaction History

Putnam Investments LLC

$73 Billion
Q4 2023

A detailed history of Putnam Investments LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 8,456,365 shares of MRK stock, worth $870 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares

8,456,365

Previous 8,128,018 4.04%

Holding current value

$870 Million

Previous $837 Million 10.17%

% of portfolio

1.26%

Previous 1.31%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $32.9 Million - $35.8 Million	328,347 Added 4.04%	8,456,365 $922 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $18.9 Million - $21 Million	-183,450 Reduced 2.21%	8,128,018 $837 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $83 Million - $90.4 Million	-763,885 Reduced 8.42%	8,311,468 $959 Million
Q1 2023 May 22, 2023	BUY	$102.94 - $114.86 $46.3 Million - $51.7 Million	449,860 Added 5.22%	9,075,353 $966 Million
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $16.1 Million - $20.6 Million	-183,691 Reduced 2.09%	8,625,493 $957 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $20.6 Million - $23.1 Million	-243,780 Reduced 2.69%	8,809,184 $759 Million
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $40.6 Million - $46 Million	485,719 Added 5.67%	9,052,964 $825 Million
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $40.8 Million - $45.7 Million	555,013 Added 6.93%	8,567,245 $703 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $135 Million - $169 Million	1,863,064 Added 30.3%	8,012,232 $614 Million
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $5.83 Million - $6.41 Million	81,281 Added 1.34%	6,149,168 $462 Million
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $88.3 Million - $97.7 Million	1,256,075 Added 26.1%	6,067,887 $472 Million
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $48.7 Million - $57.3 Million	-706,764 Reduced 12.81%	4,811,812 $371 Million
Q4 2020 Feb 16, 2021	SELL	$71.77 - $79.65 $78.2 Million - $86.8 Million	-1,089,219 Reduced 16.48%	5,518,576 $451 Million
Q3 2020 Nov 16, 2020	SELL	$73.18 - $82.95 $53.8 Million - $61 Million	-735,423 Reduced 10.01%	6,607,795 $548 Million
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $49.7 Million - $56.6 Million	-706,379 Reduced 8.78%	7,343,218 $568 Million
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $38.8 Million - $53.7 Million	611,819 Added 8.23%	8,049,597 $619 Million
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $44.2 Million - $49.8 Million	569,108 Added 8.29%	7,437,778 $676 Million
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $59.2 Million - $64.5 Million	778,047 Added 12.77%	6,868,670 $578 Million
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $17.2 Million - $20.1 Million	245,825 Added 4.21%	6,090,623 $511 Million
Q1 2019 May 15, 2019	BUY	$69.58 - $79.36 $27.6 Million - $31.5 Million	396,447 Added 7.28%	5,844,798 $486 Million
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $36.8 Million - $42.7 Million	564,279 Added 11.55%	5,448,351 $416 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $7.02 Million - $8.26 Million	-121,732 Reduced 2.43%	4,884,072 $346 Million
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $24.2 Million - $28.4 Million	475,175 Added 10.49%	5,005,804 $304 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $16.3 Million - $19 Million	320,450 Added 7.61%	4,530,629 $247 Million
Q4 2017 Feb 14, 2018	SELL	$51.62 - $61.64 $27.5 Million - $32.8 Million	-532,399 Reduced 11.23%	4,210,179 $237 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $278 Million - $299 Million	4,742,578	4,742,578 $304 Million

Others Institutions Holding MRK

# of Institutions

3,803

Shares Held

1.92B

Call Options Held

13.4M

Put Options Held

10.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Account

Putnam Investments LLC Merck & Co., Inc. Transaction History